비교리스트

 카트 문의
시장보고서
상품코드
1449363

세계의 아르보바이러스 검사 시장 : 점유율, 규모, 동향, 산업 분석 보고서 - 검사 유형별, 아르보바이러스 질환별, 최종 용도별, 지역별, 부문별 예측(2024-2032년)

Arbovirus Testing Market Share, Size, Trends, Industry Analysis Report, By Test Type (ELISA-based Tests, RT-PCR based Tests, and Others); By Arboviral Disease; By End-use; By Region; Segment Forecast, 2024- 2032
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 115 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 아르보바이러스 검사 시장 규모는 2032년까지 22억 4,000만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.

아르보바이러스 검사 시장의 성장을 가속하는 주요 요인은 절지동물 매개 바이러스 감염 환자 수 증가와 아르보바이러스 질환의 부담을 억제하기 위한 정부 프로그램 증가입니다. 예를 들어, 유럽질병예방통제센터의 데이터에 따르면 2023년 브라질과 파라과이의 치쿤구니야 환자 수는 각각 256,927명과 140,905명이었습니다. 또한 미국과 같은 국가에서 웨스트 나일 바이러스 감염 사례가 증가하고 조기 검사의 이점을 홍보하기 위한 정부 활동에 중점을 두어 향후 몇 년동안 시장 성장을 가속할 것으로 예상됩니다.

온난한 기온과 높은 습도로 인해 열대 및 아열대 지역 사람들이 경험하는 아르보바이러스성 질환의 위험 증가는 시장 확대에 도움이 될 것입니다. 또한, 아르보바이러스 질환의 부담을 관리하기 위한 자금 조달, 자원 배분 및 프로그램 수립에 대한 정부의 높은 우선순위는 시장 성장을 가속할 것입니다. 또한, 신흥국에서 황열병, 뎅기열, 치쿤구니야의 환자 수가 증가하면서 시장 성장에 기여하고 있습니다. 예를 들어, 유럽질병예방통제센터의 데이터에 따르면 2023년 필리핀의 치쿤구니야 환자 수는 2,561명이었습니다. 이러한 신흥국의 대규모 환자 수는 예측 기간 동안 아르보바이러스 검사 시장의 성장 기회가 될 것으로 보입니다.

아르보바이러스 감염증이 증가하는 주요 원인은 도시화, 기후 변화, 사람과 물자의 이동 증가 등입니다. 또한 고온다습한 기후 변화는 뎅기열 전염병의 확산 위험을 증가시켜 아르보바이러스 검사에 대한 수요를 촉진하고 있습니다. 또한, 신속한 검사에 대한 R&D 비용 증가와 함께 신제품 도입을 우선시하는 시장 기업들은 향후 몇 년동안 아르보바이러스 검사 시장의 성장을 가속할 것으로 예상됩니다.

아르보바이러스 검사 시장 보고서 하이라이트

ELISA 기반 검사 부문이 시장을 장악했습니다. 이는 이 검사와 관련된 기술 혁신, 지속적인 개선 및 기술 발전으로 인한 것입니다.

뎅기열 분야는 전 세계 뎅기열 환자 수와 사망자 수 증가로 인해 상당한 시장 점유율을 차지했습니다.

공중 보건 검사 부문이 가장 큰 시장 점유율을 차지한 것은 정부의 이니셔티브와 질병 진단 검사에 대한 자금 지원 증가에 기인합니다.

북미지역이 아르보바이러스 검사 시장을 독점한 이유는 아르보바이러스 질환 환자 수가 많고 검사량이 많기 때문입니다.

시장 기업으로는 Agilent Technologies Inc., Thermo Fisher Scientific, NovaTec Immundiagnostica GmbH, Euroimmun AG, Abbott 등이 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 아르보바이러스 검사 시장 인사이트

  • 아르보바이러스 검사 시장 - 최종 용도 현황
  • 아르보바이러스 검사 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • PESTEL 분석
  • 아르보바이러스 검사 시장 최종 용도 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 아르보바이러스 검사 시장 : 아르보바이러스 질환별

  • 주요 조사 결과
  • 서론
  • 뎅기열
  • 황열병
  • 지카 바이러스
  • 웨스트 나일 바이러스
  • 치쿵니아열
  • 기타

제6장 세계의 아르보바이러스 검사 시장 : 검사 유형별

  • 주요 조사 결과
  • 서론
  • ELISA 기반 검사
  • RT-PCR 기반 검사
  • 기타

제7장 세계의 아르보바이러스 검사 시장 : 최종 용도별

  • 주요 조사 결과
  • 서론
  • 병원
  • 진단센터
  • 공중위생 연구소
  • 기타

제8장 세계의 아르보바이러스 검사 시장 : 지역별

  • 주요 조사 결과
  • 서론
    • 아르보바이러스 검사 시장 평가 : 지역별(2019년-2032년)
  • 아르보바이러스 검사 시장 : 북미
    • 아르보바이러스 질환별
    • 최종 용도별
    • 검사 유형별
    • 미국
    • 캐나다
  • 아르보바이러스 검사 시장 : 유럽
    • 아르보바이러스 질환별
    • 최종 용도별
    • 검사 유형별
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
  • 아르보바이러스 검사 시장 : 아시아태평양
    • 아르보바이러스 질환별
    • 최종 용도별
    • 검사 유형별
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
  • 아르보바이러스 검사 시장 : 중동 및 아프리카
    • 아르보바이러스 질환별
    • 최종 용도별
    • 검사 유형별
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 남아프리카공화국
  • 아르보바이러스 검사 시장 : 라틴아메리카
    • 아르보바이러스 질환별
    • 최종 용도별
    • 검사 유형별
    • 멕시코
    • 브라질
    • 아르헨티나

제9장 경쟁 구도

  • 확장 및 인수 분석
    • 확장
    • 인수
  • 제휴/협업/합의/공개

제10장 기업 개요

  • Abbott(U.S.)
  • Agilent Technologies, Inc.,(U.S.)
  • Bio-Rad Laboratories, Inc.(U.S.)
  • Copley Scientific(UK)
  • DiaSorin SpA(Italy)
  • Euroimmun AG(Germany)
  • F. Hoffmann-La Roche Ltd(Switzerland)
  • NovaTec Immundiagnostica GmbH(Germany)
  • QIAGEN N.V.(Netherlands)
  • Thermo Fisher Scientific, Inc.(U.S.)
LSH 24.03.26

The global arbovirus testing market size is expected to reach USD 2.24 billion by 2032, according to a new study by Polaris Market Research. The report "Arbovirus Testing Market Share, Size, Trends, Industry Analysis Report, By Test Type (ELISA-based Tests, RT-PCR based Tests, and Others); By Arboviral Disease; By End-use; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The primary drivers propelling the growth of the arbovirus testing market are the rising number of patients infected with arthropod-borne viral infections and the growing number of government programs aimed at controlling the burden of arboviral diseases. For instance, according to the data from the European Centre for Disease Prevention and Control, in 2023, the number of chikungunya cases in Brazil and Paraguay were 256,927 and 140,905, respectively. Moreover, the growing cases of West Nile Virus infections in countries such as the U.S., coupled with an increased focus on government activities to promote the advantages of early testing, are expected to boost the market growth in the upcoming years.

The increased risk of arboviral diseases that people of tropical and subtropical regions experience due to warm temperatures and high humidity will be beneficial for the market expansion. Moreover, the high priority of governments on funding, allocation of resources, and establishment of programs for managing the burden of arboviral diseases drives market growth. Furthermore, rising cases of yellow fever, dengue, and chikungunya in developing countries contribute to market growth. For instance, according to the European Centre for Disease Prevention and Control's data, in 2023, the number of chikungunya cases in the Philippines was 2,561. Such a large patient pool from developing countries will provide an opportunity for the growth of the arbovirus testing market during the forecast timeframe.

The main causes for the rising incidence of arboviral infections include urbanization, climate change, and greater travel of people and goods. Moreover, the climatic changes leading to high temperatures and humidity increase the risk of spread of the dengue epidemic, thereby fueling the demand for arbovirus tests. Furthermore, market players prioritizing the introduction of new products coupled with a rise in research and development expenditures for rapid tests are expected to foster the arbovirus testing market growth in the projected years.

Arbovirus Testing Market Report Highlights

The ELISA-based tests segment dominated the market, owing to the innovation, continuous improvements, and technological advancements associated with the test.

The dengue segment accounted for a considerable market share, owing to the growing number of dengue cases and mortalities worldwide.

The public health laboratories segment accounted for the largest market share, owing to government initiatives and rising funding for diagnostic testing of diseases.

North America dominated the arbovirus testing market, owing to the presence of a large patient pool for arboviral diseases coupled with the high testing volume.

The market players include Agilent Technologies Inc., Thermo Fisher Scientific, NovaTec Immundiagnostica GmbH, Euroimmun AG, Abbott, etc.

Polaris Market Research has segmented the arbovirus testing market report based on test type, arboviral disease, end-use, and region:

Arbovirus Testing, Test Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • ELISA-based Tests
  • RT-PCR based Tests
  • Others

Arbovirus Testing, Arboviral Disease Outlook (Revenue - USD Billion, 2019 - 2032)

  • Dengue
  • Yellow Fever
  • Zika Virus
  • West Nile Virus
  • Chikungunya
  • Others

Arbovirus Testing, End-use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Diagnostic Centers
  • Public Health Laboratories
  • Others

Arbovirus Testing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Arbovirus Testing Market Insights

  • 4.1. Arbovirus Testing Market - End-use Snapshot
  • 4.2. Arbovirus Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing occurrence and resurgence of arthropod-borne viral infections
      • 4.2.1.2. Government initiatives for awareness
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Restricted access to diagnostic testing methods and lack of awareness
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Arbovirus Testing Market End-use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Arbovirus Testing Market, by Arboviral Disease

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
  • 5.3. Dengue
    • 5.3.1. Global Arbovirus Testing Market, by Dengue, by Region, 2019-2032 (USD Billion)
  • 5.4. Yellow Fever
    • 5.4.1. Global Arbovirus Testing Market, by Yellow Fever, by Region, 2019-2032 (USD Billion)
  • 5.5. Zika Virus
    • 5.5.1. Global Arbovirus Testing Market, by Zika Virus, by Region, 2019-2032 (USD Billion)
  • 5.6. West Nile Virus
    • 5.6.1. Global Arbovirus Testing Market, by West Nile Virus, by Region, 2019-2032 (USD Billion)
  • 5.7. Chikungunya
    • 5.7.1. Global Arbovirus Testing Market, by Chikungunya, by Region, 2019-2032 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Arbovirus Testing Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Arbovirus Testing Market, by Test Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
  • 6.3. ELISA-based Tests
    • 6.3.1. Global Arbovirus Testing Market, by ELISA-based Tests, by Region, 2019-2032 (USD Billion)
  • 6.4. RT-PCR based Tests
    • 6.4.1. Global Arbovirus Testing Market, by RT-PCR based Tests, by Region, 2019-2032 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Arbovirus Testing Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Arbovirus Testing Market, by End-use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Arbovirus Testing Market, by Hospitals, By Region, 2019-2032 (USD Billion)
  • 7.4. Diagnostic Centers
    • 7.4.1. Global Arbovirus Testing Market, by Diagnostic Centers, By Region, 2019-2032 (USD Billion)
  • 7.5. Public health Laboratories
    • 7.5.1. Global Arbovirus Testing Market, by Public health Laboratories, By Region, 2019-2032 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Arbovirus Testing Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Arbovirus Testing Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Arbovirus Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Arbovirus Testing Market - North America
    • 8.3.1. North America: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
    • 8.3.2. North America: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
    • 8.3.3. North America: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.3.4. Arbovirus Testing Market - U.S.
      • 8.3.4.1. U.S.: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.3.5. Arbovirus Testing Market - Canada
      • 8.3.5.1. Canada: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
  • 8.4. Arbovirus Testing Market - Europe
    • 8.4.1. Europe: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.4.4. Arbovirus Testing Market - UK
      • 8.4.4.1. UK: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.4.5. Arbovirus Testing Market - France
      • 8.4.5.1. France: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.4.6. Arbovirus Testing Market - Germany
      • 8.4.6.1. Germany: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.4.7. Arbovirus Testing Market - Italy
      • 8.4.7.1. Italy: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.4.8. Arbovirus Testing Market - Spain
      • 8.4.8.1. Spain: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.4.9. Arbovirus Testing Market - Netherlands
      • 8.4.9.1. Netherlands: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.4.10. Arbovirus Testing Market - Russia
      • 8.4.10.1. Russia: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
  • 8.5. Arbovirus Testing Market - Asia Pacific
    • 8.5.1. Asia Pacific: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.5.4. Arbovirus Testing Market - China
      • 8.5.4.1. China: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.5.5. Arbovirus Testing Market - India
      • 8.5.5.1. India: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.5.6. Arbovirus Testing Market - Malaysia
      • 8.5.6.1. Malaysia: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.5.7. Arbovirus Testing Market - Japan
      • 8.5.7.1. Japan: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.5.8. Arbovirus Testing Market - Indonesia
      • 8.5.8.1. Indonesia: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.5.9. Arbovirus Testing Market - South Korea
      • 8.5.9.1. South Korea: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
  • 8.6. Arbovirus Testing Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.6.4. Arbovirus Testing Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.6.5. Arbovirus Testing Market - UAE
      • 8.6.5.1. UAE: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.6.6. Arbovirus Testing Market - Israel
      • 8.6.6.1. Israel: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.6.7. Arbovirus Testing Market - South Africa
      • 8.6.7.1. South Africa: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
  • 8.7. Arbovirus Testing Market - Latin America
    • 8.7.1. Latin America: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.7.4. Arbovirus Testing Market - Mexico
      • 8.7.4.1. Mexico: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.7.5. Arbovirus Testing Market - Brazil
      • 8.7.5.1. Brazil: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.7.6. Arbovirus Testing Market - Argentina
      • 8.7.6.1. Argentina: Arbovirus Testing Market, by Arboviral Disease, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Arbovirus Testing Market, by End-use, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Arbovirus Testing Market, by Test Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott (U.S.)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Agilent Technologies, Inc., (U.S.)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bio-Rad Laboratories, Inc. (U.S.)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Copley Scientific (UK)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. DiaSorin SpA (Italy)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Euroimmun AG (Germany)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. F. Hoffmann-La Roche Ltd (Switzerland)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. NovaTec Immundiagnostica GmbH (Germany)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. QIAGEN N.V. (Netherlands)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Thermo Fisher Scientific, Inc. (U.S.)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제